BioPhorum Supply Resilience’s Post

🌟 Sterile Filtration: Principles, Best Practices & New Developments 🔬 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐯𝐞 𝐏𝐃𝐅: https://lnkd.in/dtXSD_Wn Sterile filtration is essential in industries from pharma to biotech, ensuring product safety by eliminating microorganisms while preserving product integrity. Key Principles: ✅ Filtration Integrity ✅ Selection of the right filter pore size (0.22 µm or smaller) ✅ Compliance with sterility standards 🚀 New Developments: Innovative filter materials and single-use technologies are transforming the efficiency and reliability of sterile filtration processes, driving better outcomes in drug development and production. 💡 Market Insights: The sterile filtration market was valued at $8.9 billion in 2023 and is projected to reach $15.3 billion by 2028, growing at a robust CAGR of 11.4%! Stay ahead of the curve by adopting best practices and exploring the latest advancements! #SterileFiltration #PharmaManufacturing #BiotechInnovation #LifeSciences #MarketGrowth #QualityAssurance #Healthcare

🧪 Major Breakthrough in Povidone-Iodine Production! We have successfully developed a groundbreaking solvent-free reactor that dramatically reduces production costs, improves efficiency, and increases the quality of porvidon-iodine. By eliminating the traditional solvent evaporation process, we've not only made the manufacturing process more sustainable but also significantly lowered the overall cost. This innovation has the potential to revolutionize the pharmaceutical industry by offering a more affordable and environmentally friendly way to produce providon iodine. 💡 Our new reactor technology offers several key advantages: - Cost Reduction: Eliminating solvent evaporation saves on energy and reduces the need of complex control measures. - Increased Efficiency: The solvent-free process shortens production time, leading to higher throughput and lower overall costs. - Improved Quality: Our reactor ensures a more consistent and higher-quality povidone-iodine product. - Improved Sustainability: By reducing the reliance on solvents, we're contributing to a more sustainable and environmentally friendly manufacturing process. 📍 This breakthrough is a testament to our commitment to innovation and our dedication to finding more efficient and sustainable solutions. We're excited to share this achievement with the industry and look forward to the positive impact it will have on the production of povidone-iodine. #innovation #pharmaceutical #sustainability #povidone_iodine #povidone #technology #qualitycontrol

Facing strict regulatory mandates, a leading pharmaceutical company recognized the urgent need to upgrade its effluent treatment system to focus on recycling and reusing treated water. 🔹 Challenge: Limited space and strict regulations created hurdles in upgrading the system while ensuring optimal efficiency. 🔹 Solution: QUA’s EnviQ® innovative submerged membrane bioreactor designed to fit their space constraints. This technology automated operations, ensuring consistent, high-quality product output. 🔹 Result: Since its installation, EnviQ has excelled, meeting all regulatory requirements while maintaining stable water chemistry and a reliable permeate flow. Pharmaceutical manufacturing processes generate complex effluents that demand efficient treatment. Discover how our EnviQ® submerged membrane bioreactor solution helped the company streamline its operations and enhance water recycling. 🔗 https://hubs.ly/Q02F0Cw30

𝗦𝗶𝗻𝗴𝗹𝗲-𝘂𝘀𝗲 𝗕𝗶𝗼𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The research report provides an in-depth overview of the Single-use Bioprocessing Systems industry chain, examining the market status of Bio-pharmacy and CDMO sectors utilizing Single-use Bioreactors and Disposable Sterile Bags. It highlights key enterprises in both developed and developing markets, while analyzing cutting-edge technologies, patents, hot applications, and market trends within Single-use Bioprocessing Systems. Regionally, the report assesses Single-use Bioprocessing Systems markets in key regions, noting steady growth in North America and Europe due to government initiatives and increasing consumer awareness, while Asia-Pacific, particularly China, leads globally with robust domestic demand, supportive policies, and a strong manufacturing base. The Single-use Bioprocessing Systems market is segmented by type and application, with precise forecasts from 2024 to 2031 for consumption value by type and application, focusing on market valuation. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗦𝗶𝗻𝗴𝗹𝗲-𝘂𝘀𝗲 𝗕𝗶𝗼𝗽𝗿𝗼𝗰𝗲𝘀𝘀𝗶𝗻𝗴 𝗦𝘆𝘀𝘁𝗲𝗺𝘀 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dt5sH_Xt *𝗕𝘆 𝗧𝘆𝗽𝗲: Single-use Bioreactors, Disposable Sterile Bags, Disposable Filtration Systems, Others *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Bio-pharmacy, CDMO, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Danaher Corporation, Thermo Fisher Scientific, Sartorius, Merck Group, Eppendorf , Getinge, LePure Biotech, ABEC, Kuhner shaker, PBS Biotech, CELL-tainer, AUSTAR Group #singleuse #bioprocessing #systems #biotechnology #lifesciences #biomanufacturing #pharmaceuticals #bioreactors #singleusebioreactors #bioproduction #biopharma #singleusetechnology #cellculture #bioengineering #processdevelopment #bioprocess #innovation #sustainability #manufacturing #drugdevelopment #biotech #researchanddevelopment #bioreactor #bioprocessingequipment #biomedicalengineering #labtechnology #bioreactorbags #sustainablebioprocessing #bioprocesssystems #bioprocesscontrol

🔉 Ecopharmacology and Drug Life Cycle Management 💉💊 Ecopharmacology brings an essential focus on the life cycle of pharmaceuticals, from synthesis to disposal. With innovative life cycle assessments (LCAs), companies can evaluate environmental impact and prioritize eco-friendly practices in the manufacturing, distribution, and waste disposal stages. Techniques like eco-design, biodegradable formulations, and take-back programs are revolutionizing drug life cycle management. Adopting such sustainable models not only mitigates ecological damage but also aligns with regulatory frameworks advocating for environmental protection. This shift towards circular pharmaceutical management ensures a sustainable future for both business and the planet. #SustainablePharma #LifeCycleAssessment #Ecopharmacology

Dive into the latest innovation in biodecontamination systems 🚀 Join us for the lecture on March 20, 2024, from 1:15 to 2pm as we discuss the upgrade of the H2O2 decontamination system for the production of the RABS Vial Filling Line. 📢 Speakers 🎤 Pasquale (Pascal) Cataldo from Roche Diagnostics Kenan Kanmaz from Optima Pharma Containment Topics 🔍 1️⃣ Current process and reasons for the upgrade as per Annex 1 2️⃣ Project challenges - timeline & installation vs. production 3️⃣ Production shutdown and implementation 4️⃣ Risks and other key tasks of upgrading 5️⃣ Results of the project, cycles development, and benefits 6️⃣ Key features and advanced technologies of DECOpulse® - Effective H2O2 biodecontamination system Don't miss the chance to learn more about the future of biodecontamination! Register with code "PT-A20" for free now and be part of it ▶ https://lnkd.in/e87XrNGf #optima #wecareforpeople #packaging #pharmacongress #biodecontamination

I'm very excited to share another #innovation news from SCHOTT Pharma: We just launched a new nest for our prefillable polymer syringes, which holds 160 instead of 100 syringes! The new design can transform the operational efficiency and sustainability efforts of our pharma customers.   By offering a nest with 160 syringes, drug manufacturers benefit from an increased output compared to the standard setup: In the same cycle time, the new nest enables pharma companies to fill significantly more syringes per hour than the nest with 100 syringes.   This translates into: An increase in efficiency by up to 67%, a significant reduction of manufacturing costs, and a reduction of the product carbon footprint by 17%.   Through this, we are actively addressing one of the main levers to improve the costs of pharma companies and reorganizing their value chain. And, it's great to see that first customers are already planning to implement the new product.   Kudos to our team for showcasing their engineering skills through this product development! It's another step toward expanding our strong position of our high-value solutions. #BecauseHumanHealthMatters

💡 This design would also be useful elsewhere (e.g. molding process), it could effectively reduce raw material waste. #ecodesign #sustainability

Cross-contamination Strategy in Pharma The key aspects for cross-contamination strategy would include facility design, personnel, material, waste flow, equipment management, cleaning and disinfection, environmental monitoring, campaign production, and segregation strategies to prevent cross-contamination in pharmaceutical facilities. #worth_reading #worth_to_read #pharma_in_tables